SEER, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
SEER, INC. (SEER) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 1.09 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-11
- SEER, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 650.84K shares, a 227.16% increase year-over-year.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 440.99K shares, a 120.65% increase year-over-year.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 383.11K shares, a 47.65% decline year-over-year.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 179.21K shares, a 76.62% decline year-over-year.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 961.12K shares, a 59.49% decline from fiscal 2024.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 2.37M shares, a 43.17% increase from fiscal 2023.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 1.66M shares, a 17.16% decline from fiscal 2022.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 2.00M shares, a 462.38% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 650.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 1.09M shares 10-Q · filed 2026-08-11 | 1.47M shares derived: sum of 3 quarters · filed 2026-08-11 | 1.65M shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 440.99K shares 10-Q · filed 2026-05-13 | 824.09K shares derived: sum of 2 quarters · filed 2026-05-13 | 1.00M shares derived: sum of 3 quarters · filed 2026-05-13 | 1.20M shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 383.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 562.32K shares derived: sum of 2 quarters · filed 2026-03-02 | 761.25K shares derived: sum of 3 quarters · filed 2026-03-02 | 961.12K shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 179.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 378.15K shares derived: sum of 2 quarters · filed 2025-11-06 | 578.01K shares 10-Q · filed 2025-11-06 | 1.31M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 198.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 398.80K shares 10-Q · filed 2025-08-06 | 1.13M shares derived: sum of 3 quarters · filed 2025-08-06 | 1.90M shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 199.86K shares 10-Q · filed 2025-05-13 | 931.68K shares derived: sum of 2 quarters · filed 2025-05-13 | 1.70M shares derived: sum of 3 quarters · filed 2025-05-13 | 1.92M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 731.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 1.50M shares derived: sum of 2 quarters · filed 2025-03-03 | 1.72M shares derived: sum of 3 quarters · filed 2025-03-03 | 2.37M shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 766.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 986.61K shares derived: sum of 2 quarters · filed 2024-11-06 | 1.64M shares 10-Q · filed 2024-11-06 | 2.45M shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 220.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 874.12K shares 10-Q · filed 2024-08-08 | 1.69M shares derived: sum of 3 quarters · filed 2024-08-08 | 2.37M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 653.92K shares 10-Q · filed 2024-05-08 | 1.47M shares derived: sum of 2 quarters · filed 2024-05-08 | 2.15M shares derived: sum of 3 quarters · filed 2024-05-08 | 2.21M shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 812.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | 1.50M shares derived: sum of 2 quarters · filed 2024-03-04 | 1.56M shares derived: sum of 3 quarters · filed 2024-03-04 | 1.66M shares 10-K · filed 2024-03-04 |
| 2023-09-30 | 684.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 742.80K shares derived: sum of 2 quarters · filed 2023-11-07 | 844.63K shares 10-Q · filed 2023-11-07 | 1.06M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 57.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 159.77K shares 10-Q · filed 2023-08-08 | 375.30K shares derived: sum of 3 quarters · filed 2023-08-08 | 1.78M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 101.83K shares 10-Q · filed 2023-05-09 | 317.36K shares derived: sum of 2 quarters · filed 2023-05-09 | 1.72M shares derived: sum of 3 quarters · filed 2023-05-09 | 2.08M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 215.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 1.62M shares derived: sum of 2 quarters · filed 2023-03-06 | 1.97M shares derived: sum of 3 quarters · filed 2023-03-06 | 2.00M shares 10-K · filed 2023-03-06 |
| 2022-09-30 | 1.40M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 1.76M shares derived: sum of 2 quarters · filed 2022-11-08 | 1.78M shares 10-Q · filed 2022-11-08 | 1.86M shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 358.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 384.63K shares 10-Q · filed 2022-08-09 | 463.46K shares derived: sum of 3 quarters · filed 2022-08-09 | 600.91K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 25.94K shares 10-Q · filed 2022-05-06 | 104.77K shares derived: sum of 2 quarters · filed 2022-05-06 | 242.23K shares derived: sum of 3 quarters · filed 2022-05-06 | 300.45K shares derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-12-31 | 78.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 216.28K shares derived: sum of 2 quarters · filed 2022-03-01 | 274.51K shares derived: sum of 3 quarters · filed 2022-03-01 | 355.71K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 137.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 195.68K shares derived: sum of 2 quarters · filed 2021-11-09 | 276.88K shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | 58.22K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 139.42K shares 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 81.20K shares 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |